Format

Send to

Choose Destination
Nat Nanotechnol. 2009 Oct;4(10):627-33. doi: 10.1038/nnano.2009.241. Epub 2009 Sep 27.

Promises, facts and challenges for carbon nanotubes in imaging and therapeutics.

Author information

1
Nanomedicine Laboratory, Centre for Drug Delivery Research, The School of Pharmacy, University of London, London WC1N 1AX, UK. kostas.kostarelos@pharmacy.ac.uk

Abstract

The use of carbon nanotubes in medicine is now at the crossroads between a proof-of-principle concept and an established preclinical candidate for a variety of therapeutic and diagnostic applications. Progress towards clinical trials will depend on the outcomes of efficacy and toxicology studies, which will provide the necessary risk-to-benefit assessments for carbon-nanotube-based materials. Here we focus on carbon nanotubes that have been studied in preclinical animal models, and draw attention to the promises, facts and challenges of these materials as they transition from research to the clinical phase. We address common questions regarding the use of carbon nanotubes in disease imaging and therapy, and highlight the opportunities and challenges ahead.

Comment in

PMID:
19809452
DOI:
10.1038/nnano.2009.241
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center